Sodium Channel inhibitor 1
PF 04531083
(R)-(-)-Repaglinide(Repaglinide Impurity)
Dapagliflozin Hydroxy Impurity
Repaglinide-ethyl-d5
Tadalafil Ketolactam(>90%)
Cefetamet
CP-547632 hydrochloride
CIS-4-庚烯醇
PNU-120596
cIAP1 Ligand-Linker Conjugates 15
Thalidomide-O-amido-C4-NH2(TFA)
NecroX-5
Voxtalisib
7-Bromo-L-tryptophan
Potassium Neodecanoate
(S)-N-Methyl-d5 Pregabalin
Flumazenil acid
二花生烯酸甘油酯
Dabrafenib-d9
Nalfurafine
RAF 265
Furafylline-d3
Enocyanin
[pTyr5] EGFR 988-993
Doxycycline hydrochloride
Flupirtine
PEAQX
Org-26576
MRK-016
AS1949490
Isotanshinone IIA
Raphin1 acetate
Licoflavone A
(E/Z)-BCI
Epimetendiol
Metopimazine-d6
Metopimazine
Δ2-Cefepime
DO-264
Elamipretide TFA
Mitochonic acid 5
AZ876
LXR-623
Eleclazine hydrochloride
Lansoprazole sodium
Istaroxime
Caldaret
NFPS
CTS-1027
Incyclinide
MMP-9-IN-1
NO-冯-PBnPPr
(S)-(+)-4-Phenyl-2-butanol
1-(正戊基)环戊醇,98%
4-bromo-2-{(E)-[(3-ethylphenyl)imino]methyl}phenol
3,3-dimethyl-4-(oxolan-2-yl)azetidin-2-one
4-(oxolan-3-yloxy)aniline
RP 48497(Eszopiclone Impurity C)
YW3-56
